Update to my previous article on vaccine induced blood problems
New research data documents vaccine medical impact
If you are concerned about COVID vaccines read this previous article. It is filled with compelling data and information on substantial blood problems associated with vaccine shots that result in serious medical impacts.
A newly published medical report further documents heart problems resulting from vaccine shots.
A new study of 566 patients who received either the Pfizer or Moderna vaccines shows that signs of cardiovascular damage soared following the shots.
The risk of heart attacks or other severe coronary problems more than doubled months after the vaccines were administered, based on changes in markers of inflammation and other cell damage.
Patients had a 1 in 4 risk for severe problems after the vaccines, compared to 1 in 9 before.
Dr. Steven Grundy, a Nebraska physician and retired cardiac surgeon, presented the findings at the Scientific Sessions of the American Heart Association’s annual conference in Boston last week. The abstract is given below. Dr. Gundry regularly tests patients for early signs of heart problems, such as inflammation and cellular death. The patients are then given a score designed to predict their risk of developing an acute coronary syndrome in the next five years.
Here is the published abstract from an American Heart Association conference for those of you who like to read medical details:
Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: A Warning
Steven R Gundry
Originally published 8 Nov 2021Circulation. 2021;144:A10712
Abstract
Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS). The score is based on changes from the norm of multiple protein biomarkers including IL-16, a proinflammatory cytokine, soluble Fas, an inducer of apoptosis, and Hepatocyte Growth Factor (HGF)which serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue, among other markers. Elevation above the norm increases the PULS score, while decreases below the norm lowers the PULS score.
The score has been measured every 3-6 months in our patient population for 8 years. Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients.
This report summarizes those results. A total of 566 patients, aged 28 to 97, M:F ratio 1:1 seen in a preventive cardiology practice had a new PULS test drawn from 2 to 10 weeks following the 2nd COVID shot and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot. [This before and after method is compelling.]
Baseline IL-16 increased from 35=/-20 above the norm to 82 =/- 75 above the norm post-vac; sFas increased from 22+/- 15 above the norm to 46=/-24 above the norm post-vac; HGF increased from 42+/-12 above the norm to 86+/-31 above the norm post-vac.
These changes resulted in an increase of the PULS score from 11% 5 yr ACS risk to 25% 5 yr ACS risk. [Acute Coronary Syndrome]
At the time of this report, these changes persist for at least 2.5 months post second dose of vac.
We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.
[emphasis added]